Local and systemic effects of cat allergen nasal provocation

Clinical and Experimental Allergy

Volumn 45, Issue 3, 2015, Pages 613-623

  Scadding, G W ^a   Eifan, A ^a   Penagos, M ^a   Dumitru, A ^a   Switzer, A ^a   Mcmahon, O ^a   Phippard, D ^b   Togias, A ^c   Durham, S R ^a   Shamji, M H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Immune Tolerance Network   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Basophil; Cat allergy; Cytokine; Nasal allergen challenge; Tryptase

Indexed keywords

ALLERGEN; CAT ALLERGEN; CD63 ANTIGEN; EOTAXIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; POLYURETHAN; TRYPTASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; IMMUNOGLOBULIN E;

ADULT; ALLERGY; ALLERGY RAPID TEST; ARTICLE; BASOPHIL; CAT; CAT ALLERGY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MALE; MIDDLE AGED; NOSE MUCUS; NOSE PROVOCATION TEST; PEAK EXPIRATORY FLOW; PEAK NASAL INSPIRATORY FLOW; PRIORITY JOURNAL; YOUNG ADULT; ANIMAL; BLOOD; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; METABOLISM; NOSE MUCOSA; PROCEDURES; SECRETION (PROCESS);

ADULT; ALLERGENS; ANIMALS; BASOPHILS; BIOMARKERS; CATS; CYTOKINES; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL PROVOCATION TESTS; YOUNG ADULT;

EID: 84923513231     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12434     Document Type: Article

References (39)

1. Bollinger ME, Wood RA, Chen P, Eggleston PA. Measurement of cat allergen levels in the home by use of an amplified ELISA. J Allergy Clin Immunol 1998; 101:124-5.
2. Arbes SJ, Sever M, Mehta J, Collette N, Thomas B, Zeldin DC. Exposure to indoor allergens in day-care facilities: results from 2 North Carolina counties. J Allergy Clin Immunol 2005; 116:133-9.
3. Almqvist C, Larsson PH, Egmar AC, Hedrén M, Malmberg P, Wickman M. School as a risk environment for children allergic to cats and a site for transfer of cat allergen to homes. J Allergy Clin Immunol 1999; 103:1012-7.
4. Almqvist C, Wickman M, Perfetti L et al. Worsening of asthma in children allergic to cats, after indirect exposure to cat at school. Am J Respir Crit Care Med 2001; 163:694-8.
5. Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005; 116:377-83.
6. Gruchalla RS, Pongracic J, Plaut M et al. Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol 2005; 115:478-85.
7. Wood RA, Johnson EF, Van Natta ML, Chen PH, Eggleston PA. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med 1998; 158:115-20.
8. Woodfolk JA. High-dose allergen exposure leads to tolerance. Clin Rev Allergy Immunol 2005; 28:43-58.
9. Patel D, Couroux P, Hickey P et al. Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study. J Allergy Clin Immunol 2013; 131:103-9.
10. Gaspar Elsas MI, Joseph D, Elsas PX, Vargaftig BB. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 1997; 17:404-13.
11. Wood LJ, Inman MD, Watson RM, Foley R, Denburg JA, O'Byrne PM. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1998; 157:99-105.
12. Borish L. Allergic rhinitis: systemic inflammation and implications for management. J Allergy Clin Immunol 2003; 112:1021-31.
13. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161:2051-7.
14. Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107:469-76.
15. Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 2004; 113:415-9.
16. Saini S, Bloom DC, Bieneman A, Vasagar K, Togias A, Schroeder J. Systemic effects of allergen exposure on blood basophil IL-13 secretion and Fc-epsilon-RI-beta. J Allergy Clin Immunol 2004; 114:768-74.
17. Scadding GW, Calderon MA, Bellido V et al. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes. J Immunol Methods 2012; 384:25-32.
18. Scadding G. Cytokine profiles in allergic rhinitis. Curr Allergy Asthma Rep 2014; 14:435.
19. Bousquet J, Clark TJ, Hurd S et al. GINA guidelines on asthma and beyond. Allergy 2007; 62:102-12.
20. Bousquet J, Lebel B, Dhivert H, Bataille Y, Martinot B, Michel FB. Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy. Clin Allergy 1987; 17:529-36.
21. Banfield G, Watanabe H, Scadding G et al. CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses. Allergy 2010; 65:1126-33.
22. Corren J, Wood RA, Patel D et al. Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge. J Allergy Clin Immunol 2011; 127:398-405.
23. Wood RA, Laheri AN, Eggleston PA. The aerodynamic characteristics of cat allergen. Clin Exp Allergy 1993; 23:733-9.
24. Sicherer SH, Wood RA, Eggleston PA. Determinants of airway responses to cat allergen: comparison of environmental challenge to quantitative nasal and bronchial allergen challenge. J Allergy Clin Immunol 1997; 99:798-805.
25. Arvidsson MB, Löwhagen O, Rak S. Early and late phase asthmatic response in lower airways of cat-allergic asthmatic patients-a comparison between experimental and environmental allergen challenge. Allergy 2007; 62:488-94.
26. Hanf G, Noga O, O'Connor A, Kunkel G. Omalizumab inhibits allergen challenge-induced nasal response. Eur Respir J 2004; 23:414-8.
27. Nanda A, O'connor M, Anand M et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol 2004; 114:1339-44.
28. Ewbank PA, Murray J, Sanders K, Curran-Everett D, Dreskin S, Nelson HS. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J Allergy Clin Immunol 2003; 111:155-61.
29. Eckman JA, Sterba PM, Kelly D et al. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol 2010; 125: 889-95.e7.
30. Phipatanakul W, Kesavanathan J, Eggleston PA, Johnson EF, Wood RA. The value of acoustic rhinometry in assessing nasal responses to cat exposure. J Allergy Clin Immunol 1998; 102:896-901.
31. Paterniti M, Kelly DC, Eckman JA et al. Cat allergen-induced blood basophil reactivity in vitro predicts acute human nasal allergen challenge responses in vivo. Clin Exp Allergy 2011; 41:963-9.
32. Cockcroft DW, Davis BE, Boulet LP et al. The links between allergen skin test sensitivity, airway responsiveness and airway response to allergen. Allergy 2005; 60:56-9.
33. Baroody FM, Mucha SM, Detineo M, Naclerio RM. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008; 121:1126-32.e7.
34. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992; 90:250-6.
35. Lönnkvist K, Moshfegh A, Pedroletti C, Hedlin G, Halldén G, Lundahl J. Increased eosinophil transmigration after nasal allergen challenge in children with allergic asthma and rhinitis. Allergy 2002; 57:1200-4.
36. Wood RA, Eggleston PA. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure. Am J Respir Crit Care Med 1995; 151:315-20.
37. Bagnasco M, Mariani G, Passalacqua G et al. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 1997; 100:122-9.
38. Liu W, Xia W, Fan Y et al. Elevated serum osteopontin level is associated with blood eosinophilia and asthma comorbidity in patients with allergic rhinitis. J Allergy Clin Immunol 2012; 130:1416-8.
39. Ciprandi G. Serum interleukin 9 in allergic rhinitis. Ann Allergy Asthma Immunol 2010; 104:180-1.